These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 14571079)

  • 21. Adult patients with moderate atopic dermatitis: tacrolimus ointment versus pimecrolimus cream.
    Abramovits W; Fleischer AB; Jaracz E; Breneman D
    J Drugs Dermatol; 2008 Dec; 7(12):1153-8. PubMed ID: 19137769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case of facial keratosis follicularis squamosa resembling atrophic acne scarring, successfully treated with topical pimecrolimus.
    Lu Y; Zhang MH; Zhu WY
    Indian J Dermatol Venereol Leprol; 2011; 77(1):69-70. PubMed ID: 21220887
    [No Abstract]   [Full Text] [Related]  

  • 23. Targeted and combination treatments for vitiligo. Comparative evaluation of different current modalities in 458 subjects.
    Lotti T; Buggiani G; Troiano M; Assad GB; Delescluse J; De Giorgi V; Hercogova J
    Dermatol Ther; 2008 Jul; 21 Suppl 1():S20-6. PubMed ID: 18727812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical 0.05% clobetasol propionate versus 1% pimecrolimus ointment in vitiligo.
    Coskun B; Saral Y; Turgut D
    Eur J Dermatol; 2005; 15(2):88-91. PubMed ID: 15757818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of tarcrolimus cream 0.1% in the treatment of vitiligo.
    Xu AE; Zhang DM; Wei XD; Huang B; Lu LJ
    Int J Dermatol; 2009 Jan; 48(1):86-90. PubMed ID: 19126059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitiligo: a potential autoimmune sequela of DRESS syndrome.
    Lonowski S; Hau J; Worswick S
    Br J Dermatol; 2016 Sep; 175(3):642-4. PubMed ID: 27038429
    [No Abstract]   [Full Text] [Related]  

  • 27. Two therapeutic challenges: periocular and genital vitiligo in children successfully treated with pimecrolimus cream.
    Souza Leite RM; Craveiro Leite AA
    Int J Dermatol; 2007 Sep; 46(9):986-9. PubMed ID: 17822508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment with pimecrolimus cream 1% clears irritant dermatitis of the periocular region, face and neck.
    Mensing CO; Mensing CH; Mensing H
    Int J Dermatol; 2008 Sep; 47(9):960-4. PubMed ID: 18937664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness and safety of topical tacrolimus monotherapy for repigmentation in vitiligo: a comprehensive literature review.
    Sisti A; Sisti G; Oranges CM
    An Bras Dermatol; 2016 Apr; 91(2):187-95. PubMed ID: 27192518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Occlusive treatment enhances efficacy of tacrolimus 0.1% ointment in adult patients with vitiligo: results of a placebo-controlled 12-month prospective study.
    Hartmann A; Bröcker EB; Hamm H
    Acta Derm Venereol; 2008; 88(5):474-9. PubMed ID: 18779885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benefits from the use of a pimecrolimus-based treatment in the management of atopic dermatitis in clinical practice. Analysis of a Swiss cohort.
    Simon D; Lübbe J; Wüthrich B; Wiesner A; Weber MM; Laffitte E; Anliker MD; Schöni MH; Braathen LR; Schmid-Grendelmeier P; Gilgen Bobalj N; Schneider D
    Dermatology; 2006; 213(4):313-8. PubMed ID: 17135737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Response of vitiligo to once- vs. twice-daily topical tacrolimus: a controlled prospective, randomized, observer-blinded trial.
    Radakovic S; Breier-Maly J; Konschitzky R; Kittler H; Sator P; Hoenigsmann H; Tanew A
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):951-3. PubMed ID: 19496898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An open-label efficacy pilot study with pimecrolimus cream 1% in adults with facial seborrhoeic dermatitis infected with HIV.
    de Moraes AP; de Arruda EA; Vitoriano MA; de Moraes Filho MO; Bezerra FA; de Magalhães Holanda E; de Moraes ME
    J Eur Acad Dermatol Venereol; 2007 May; 21(5):596-601. PubMed ID: 17447972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of narrow band ultraviolet B phototherapy as monotherapy or combination therapy for vitiligo: a meta-analysis.
    Li R; Qiao M; Wang X; Zhao X; Sun Q
    Photodermatol Photoimmunol Photomed; 2017 Jan; 33(1):22-31. PubMed ID: 27696531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two therapeutic challenges: facial vitiligo successfully treated with 1% pimecrolimus cream and 0.005% calcipotriol cream.
    Bilaç DB; Ermertcan AT; Sahin MT; Oztürkcan S
    J Eur Acad Dermatol Venereol; 2009 Jan; 23(1):72-3. PubMed ID: 18355205
    [No Abstract]   [Full Text] [Related]  

  • 36. Experience with repetitive use of pimecrolimus: exploring the effective and safe use in the treatment of relapsing seborrheic dermatitis.
    Tatlican S; Eren C; Oktay B; Eskioglu F; Durmazlar PK
    J Dermatolog Treat; 2010 Mar; 21(2):83-5. PubMed ID: 19391059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of localized vitiligo with ulobetasol cream.
    Liu XQ; Shao CG; Jin PY; Wang HQ; Ye GY; Yawalkar S
    Int J Dermatol; 1990 May; 29(4):295-7. PubMed ID: 2370121
    [No Abstract]   [Full Text] [Related]  

  • 38. Tacrolimus ointment is more effective than pimecrolimus cream in adult patients with moderate to very severe atopic dermatitis.
    Fleischer AB; Abramovits W; Breneman D; Jaracz E;
    J Dermatolog Treat; 2007; 18(3):151-7. PubMed ID: 17538803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microdermabrasion and topical tacrolimus: A novel combination therapy of vitiligo.
    Abd-Elazim NE; Yassa HA; Mahran AM
    J Cosmet Dermatol; 2020 Jun; 19(6):1447-1455. PubMed ID: 31668003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical tacrolimus for repigmentation of vitiligo.
    Grimes PE; Soriano T; Dytoc MT
    J Am Acad Dermatol; 2002 Nov; 47(5):789-91. PubMed ID: 12399778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.